Apply Defense Health Agency –Procedural Instruction (DHA-PI) 6025.29 requirements and updated 2021 Centers for Disease Control and Prevention (CDC)/U.S. Public Health Service (USPHS) Clinical Practice Guideline (CPG) recommendations. |
|
|
|
|
|
|
|
Outline how to prescribe medication regimens that are proven safe and effective for HIV-negative patients who meet recommended screening criteria for Pre-exposure prophylaxis (PrEP) initiation to reduce their risk of HIV acquisition. |
|
|
|
|
|
|
|
Educate nurses about HIV PrEP medications, side effects, contraindications, and Food and Drug Administration (FDA)-approved regimens to maximize safe use. |
|
|
|
|
|
|
|
Describe different tools Public Health nurses may use to improve clinical challenges that may present. |
|
|
|
|
|
|
|
Identify techniques to provide support for medication adherence to help patients achieve and maintain protective levels of medication in their bodies. |
|
|
|
|
|
|
|
Explain HIV risk reduction techniques, prevention services, and/or infectious diseases specialist referral resources. |
|
|
|
|
|
|
|
Identify recommended schedule for monitoring patients to detect HIV infection, medication toxicities, and levels of risk behavior to make indicated changes in strategies and support patients’ long-term health. |
|
|
|
|
|
|
|